101 related articles for article (PubMed ID: 21646742)
61. Allopurinol and progression of CKD and cardiovascular events: long-term follow-up of a randomized clinical trial.
Goicoechea M; Garcia de Vinuesa S; Verdalles U; Verde E; Macias N; Santos A; Pérez de Jose A; Cedeño S; Linares T; Luño J
Am J Kidney Dis; 2015 Apr; 65(4):543-9. PubMed ID: 25595565
[TBL] [Abstract][Full Text] [Related]
62. Comparison between urine albumin-to-creatinine ratio and urine protein dipstick testing for prevalence and ability to predict the risk for chronic kidney disease in the general population (Iwate-KENCO study): a prospective community-based cohort study.
Koeda Y; Tanaka F; Segawa T; Ohta M; Ohsawa M; Tanno K; Makita S; Ishibashi Y; Itai K; Omama SI; Onoda T; Sakata K; Ogasawara K; Okayama A; Nakamura M
BMC Nephrol; 2016 May; 17(1):46. PubMed ID: 27169575
[TBL] [Abstract][Full Text] [Related]
63. Higher Serum Levels of Osteoglycin Are Associated with All-Cause Mortality and Cardiovascular and Cerebrovascular Events in Patients with Advanced Chronic Kidney Disease.
Baek SH; Cha RH; Kang SW; Park CW; Cha DR; Kim SG; Yoon SA; Kim S; Han SY; Park JH; Chang JH; Lim CS; Kim YS; Na KY
Tohoku J Exp Med; 2017 Aug; 242(4):281-290. PubMed ID: 28824047
[TBL] [Abstract][Full Text] [Related]
64. Cystatin C as a predictor of mortality in elderly patients with chronic kidney disease.
Bevc S; Hojs N; Knehtl M; Ekart R; Hojs R
Aging Male; 2019 Mar; 22(1):62-67. PubMed ID: 29912597
[TBL] [Abstract][Full Text] [Related]
65. GlycA, a Pro-Inflammatory Glycoprotein Biomarker, and Incident Cardiovascular Disease: Relationship with C-Reactive Protein and Renal Function.
Gruppen EG; Riphagen IJ; Connelly MA; Otvos JD; Bakker SJ; Dullaart RP
PLoS One; 2015; 10(9):e0139057. PubMed ID: 26398105
[TBL] [Abstract][Full Text] [Related]
66. Chronic kidney disease, inflammation, and cardiovascular disease risk in rheumatoid arthritis.
Kochi M; Kohagura K; Shiohira Y; Iseki K; Ohya Y
J Cardiol; 2018 Mar; 71(3):277-283. PubMed ID: 28969969
[TBL] [Abstract][Full Text] [Related]
67. Association of serum adiponectin concentration with aortic arterial stiffness in chronic kidney disease: from the KNOW-CKD study.
Kim CS; Bae EH; Ma SK; Park SK; Lee JY; Chung W; Lee K; Kim YH; Oh KH; Ahn C; Kim SW;
Clin Exp Nephrol; 2017 Aug; 21(4):608-616. PubMed ID: 27514393
[TBL] [Abstract][Full Text] [Related]
68. Estimating the glomerular filtration rate in the Spanish working population: chronic kidney disease prevalence and its association with risk factors.
Sánchez-Chaparro MA; Calvo-Bonacho E; González-Quintela A; Cabrera M; Quevedo-Aguado L; Fernández-Labandera C; Ruiz-Moraga M; Sainz-Gutiérrez JC; Gómez-Martínez P; Román-García J; Felices PV; Ruilope LM; Zanchetti A;
J Hypertens; 2014 Oct; 32(10):1970-8; discussion 1978. PubMed ID: 25023154
[TBL] [Abstract][Full Text] [Related]
69. Plasma beta-2 microglobulin is associated with cardiovascular disease in uremic patients.
Liabeuf S; Lenglet A; Desjardins L; Neirynck N; Glorieux G; Lemke HD; Vanholder R; Diouf M; Choukroun G; Massy ZA;
Kidney Int; 2012 Dec; 82(12):1297-303. PubMed ID: 22895515
[TBL] [Abstract][Full Text] [Related]
70. Impact of Mild-to-Moderate Chronic Kidney Disease on One Year Outcomes after Percutaneous Coronary Intervention.
Grandjean-Thomsen NL; Marley P; Shadbolt B; Farshid A
Nephron; 2017; 137(1):23-28. PubMed ID: 28478459
[TBL] [Abstract][Full Text] [Related]
71. Epicardial fat accumulation, cardiometabolic profile and cardiovascular events in patients with stages 3-5 chronic kidney disease.
Cordeiro AC; Amparo FC; Oliveira MA; Amodeo C; Smanio P; Pinto IM; Lindholm B; Stenvinkel P; Carrero JJ
J Intern Med; 2015 Jul; 278(1):77-87. PubMed ID: 25556720
[TBL] [Abstract][Full Text] [Related]
72. Associations of plasma pentraxin 3 and monocyte chemoattractant protein-1 concentrations with cardiovascular disease in patients with chronic kidney disease.
Nishi K; Imamura T; Kitamura K; Ogawa T; Fujimoto S; Kakitsubata Y; Ishikawa T; Asada Y; Kodama T
Ren Fail; 2011; 33(4):398-404. PubMed ID: 21529268
[TBL] [Abstract][Full Text] [Related]
73. Prognostic value of combined target-organ damage in patients with essential hypertension.
Carpinella G; Pagano G; Buono F; Petitto M; Guarino G; Orefice G; Rengo G; Trimarco B; Morisco C
Am J Hypertens; 2015 Jan; 28(1):127-34. PubMed ID: 24936579
[TBL] [Abstract][Full Text] [Related]
74. Association between serum Na-Cl level and renal function decline in chronic kidney disease: results from the chronic kidney disease Japan cohort (CKD-JAC) study.
Maruta Y; Hasegawa T; Yamakoshi E; Nishiwaki H; Koiwa F; Imai E; Hishida A
Clin Exp Nephrol; 2019 Feb; 23(2):215-222. PubMed ID: 30168046
[TBL] [Abstract][Full Text] [Related]
75. The Association between Serum Retinol-Binding Protein 4 Levels and Cardiovascular Events in Patients with Chronic Kidney Disease.
Su Y; Huang Y; Jiang Y; Zhu M
Lab Med; 2020 Sep; 51(5):491-497. PubMed ID: 31999339
[TBL] [Abstract][Full Text] [Related]
76. Association of hsCRP, white blood cell count and ferritin with renal outcome in chronic kidney disease patients.
Tsai YC; Hung CC; Kuo MC; Tsai JC; Yeh SM; Hwang SJ; Chiu YW; Kuo HT; Chang JM; Chen HC
PLoS One; 2012; 7(12):e52775. PubMed ID: 23300770
[TBL] [Abstract][Full Text] [Related]
77. Smoking habit as a risk amplifier in chronic kidney disease patients.
Provenzano M; Serra R; Michael A; Bolignano D; Coppolino G; Ielapi N; Serraino GF; Mastroroberto P; Locatelli F; De Nicola L; Andreucci M
Sci Rep; 2021 Jul; 11(1):14778. PubMed ID: 34285279
[TBL] [Abstract][Full Text] [Related]
78. Circulating CD5L is associated with cardiovascular events and all-cause mortality in individuals with chronic kidney disease.
Castelblanco E; Sarrias MR; Betriu À; Soldevila B; Barranco-Altirriba M; Franch-Nadal J; Valdivielso JM; Bermudez-Lopez M; Groop PH; Fernández E; Alonso N; Mauricio D
Aging (Albany NY); 2021 Oct; 13(19):22690-22709. PubMed ID: 34629330
[TBL] [Abstract][Full Text] [Related]
79. Cardiac troponin and C-reactive protein for predicting all-cause and cardiovascular mortality in patients with chronic kidney disease: a meta-analysis.
Li WJ; Chen XM; Nie XY; Zhang J; Cheng YJ; Lin XX; Wu SH
Clinics (Sao Paulo); 2015 Apr; 70(4):301-11. PubMed ID: 26017799
[TBL] [Abstract][Full Text] [Related]
80. The Relationship Between Interleukin-4 Levels and Cardiovascular Events in Patients with Chronic Kidney Disease.
Gu L; Liu H; Liu X; Zeng X; Lei Z; Wan X
Risk Manag Healthc Policy; 2020; 13():2371-2377. PubMed ID: 33173361
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
